Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Sharan Randhawa"'
Autor:
Sharan Randhawa, Natasha Griffiths, Paul O’Brien, Charlotte Panter, Kieran Boparai, Richard Harrad, Nausheen Khuddus, Ann Webber, Christine Bouchet, Federico Felizzi
Publikováno v:
Ophthalmology and Therapy, Vol 12, Iss 5, Pp 2505-2528 (2023)
Abstract Introduction Amblyopia is a reduction in vision in one or both eyes due to impaired development of the visual pathway. This study explored the experience of amblyopia and treatment from the patient, caregiver, and clinician perspectives. Met
Externí odkaz:
https://doaj.org/article/69333b935938451e8eacc891fdacbfb0
Autor:
Ann Webber, Sharan Randhawa, Federico Felizzi, Mercedesz Soos, Rob Arbuckle, Paul O’Brien, Richard Harrad, Nausheen Khuddus, Christine Bouchet, Charlotte Panter
Publikováno v:
Ophthalmology and Therapy, Vol 12, Iss 2, Pp 1281-1313 (2023)
Abstract Introduction Amblyopia is a neurodevelopmental vision disorder, characterized by poor vision in one or both eyes. Given the lack of existing clinical outcome assessments (COA) considered fit-for-purpose for amblyopia clinical trials, this st
Externí odkaz:
https://doaj.org/article/e2df6c57c63c4b129b1fe9b3e0b42c1a
Autor:
Yanfen Guan, Allison M. Nguyen, Samantha Wratten, Sharan Randhawa, Jessica Weaver, Felipe Arbelaez, Arnaud Fauconnier, Charlotte Panter
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 6, Iss 1, Pp 1-14 (2022)
Abstract Purpose Endometriosis is a chronic disorder of the female reproductive system characterized by debilitating symptoms, particularly endometriosis-related pain (ERP). Patient-reported outcome (PRO) measures of symptoms and impacts are required
Externí odkaz:
https://doaj.org/article/98dd1f463231412faaa18727ec7a4fcc
Autor:
Tina Duong, Jessica Braid, Hannah Staunton, Aurelie Barriere, Fani Petridis, Johannes Reithinger, Rosangel Cruz, Jill Jarecki, Mencia De Lemus, Nicole Gusset, Ria Broekgaarden, Sharan Randhawa, Jessica Flynn, Rob Arbuckle, Sonia Reif, Lida Yang, Angela De Martini, Carole Vuillerot
Publikováno v:
BMC Neurology, Vol 21, Iss 1, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/3e7969a63e0b479d964476d929ecea58
Autor:
Tina Duong, Jessica Braid, Hannah Staunton, Aurelie Barriere, Fani Petridis, Johannes Reithinger, Rosangel Cruz, Jill Jarecki, Mencia De Lemus, Nicole Gusset, Ria Broekgaarden, Sharan Randhawa, Jessica Flynn, Rob Arbuckle, Sonia Reif, Lida Yang, Angela De Martini, Carole Vuillerot
Publikováno v:
BMC Neurology, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background The 32-item Motor Function Measure (MFM32) is a clinician-reported outcome measure used to assess the functional abilities of individuals with neuromuscular diseases, including those with spinal muscular atrophy (SMA). This two-pa
Externí odkaz:
https://doaj.org/article/40a4d4e72db647e4b617a358a6c10774
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 4, Iss 1, Pp 1-13 (2020)
Abstract Background The lower-risk (low and intermediate-1 risk based on IPSS) myelodysplastic syndrome (MDS) has a negative impact on patients’ health-related quality of life (HRQoL). Patient Reported Outcomes (PROs) instruments, which are used to
Externí odkaz:
https://doaj.org/article/779326d4e0a64bd2a5b5ad52b1f0cdd3
Autor:
Tina Duong, Hannah Staunton, Jessica Braid, Aurelie Barriere, Ben Trzaskoma, Ling Gao, Tom Willgoss, Rosangel Cruz, Nicole Gusset, Ksenija Gorni, Sharan Randhawa, Lida Yang, Carole Vuillerot
Publikováno v:
Frontiers in Neurology, Vol 12 (2022)
The 32-item Motor Function Measure (MFM32) is an assessment of motor function used to evaluate fine and gross motor ability in patients with neuromuscular disorders, including spinal muscular atrophy (SMA). Reliability and validity of the MFM32 have
Externí odkaz:
https://doaj.org/article/bfda0d067a5e46119881b84dee5d1662
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 4, Iss 1, Pp 1-13 (2020)
Journal of Patient-Reported Outcomes
Journal of Patient-Reported Outcomes
Background The lower-risk (low and intermediate-1 risk based on IPSS) myelodysplastic syndrome (MDS) has a negative impact on patients’ health-related quality of life (HRQoL). Patient Reported Outcomes (PROs) instruments, which are used to collect
Publikováno v:
Journal of Bronchology & Interventional Pulmonology. 27:e19-e22
Autor:
Fani Petridis, Lida Yang, Jessica Flynn, Jill Jarecki, Angela De Martini, Johannes Reithinger, Rob Arbuckle, Ria Broekgaarden, Sonia Reif, Hannah Staunton, Tina Duong, Aurelie Barriere, Carole Vuillerot, Nicole Gusset, Jessica Braid, Sharan Randhawa, Mencia de Lemus, Rosangel Cruz
Publikováno v:
BMC Neurology
BMC Neurology, BioMed Central, 2021, 21 (1), pp.143. ⟨10.1186/s12883-021-02166-z⟩
BMC Neurology, 2021, 21 (1), pp.143. ⟨10.1186/s12883-021-02166-z⟩
BMC Neurology, Vol 21, Iss 1, Pp 1-14 (2021)
BMC Neurology, BioMed Central, 2021, 21 (1), pp.143. ⟨10.1186/s12883-021-02166-z⟩
BMC Neurology, 2021, 21 (1), pp.143. ⟨10.1186/s12883-021-02166-z⟩
BMC Neurology, Vol 21, Iss 1, Pp 1-14 (2021)
Background The 32-item Motor Function Measure (MFM32) is a clinician-reported outcome measure used to assess the functional abilities of individuals with neuromuscular diseases, including those with spinal muscular atrophy (SMA). This two-part study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::527932df41f923d6b9d4fa7442fdada2
https://www.hal.inserm.fr/inserm-03310641
https://www.hal.inserm.fr/inserm-03310641